SIP
ARIA

Stoneridge Investment Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Stoneridge Investment Partners’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-52,458
Closed -$328K – 348
2015
Q4 		$328K Buy
52,458
+32,904
+168% +$216K 0.04% 234
2015
Q3 		$114K Buy
+19,554
New +$151K 0.02% 274
2015
Q2 		– Sell
-108,765
Closed -$896K – 317
2015
Q1 		$896K Buy
+108,765
New +$804K 0.11% 182

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Stoneridge Investment Partners's ARIA Position: Q1 2016 in Review

Stoneridge Investment Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 52,458 shares — an estimated $328K sold.

Stoneridge Investment Partners first reported a position in ARIA in Q1 2015 and held it in 3 quarters. The position peaked at $896K in Q1 2015. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

  • Stoneridge Investment Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 52,458 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $328K.
  • Stoneridge Investment Partners first reported a position in Ariad Pharmaceuticals Inc in Q1 2015 and held it in 3 quarters.
  • Stoneridge Investment Partners's Ariad Pharmaceuticals Inc position peaked at $896K in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Stoneridge Investment Partners's 13F filing for Q1 2016, filed 29 Apr 2016.